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ABSTRACT
Maggot debridement therapy is the application of fly larvae to a necrotic
wound. Once popular in the 1930s and1940s, its use declined with the
introduction of antibiotics, improvement of aseptic wound care, more aggressive
surgical debridement techniques, and its unacceptability by the public. The
purpose of this study was to gain a better understanding of maggot therapy, its
clinical implications, and to review a medical chart of a Wyoming patient who
received this treatment. The material is presented in one concise resource and
the protocol included can be evaluated by other clinics using maggot therapy.

A medical chart review was completed of one patient who received
maggot therapy two years ago in preparation for a skin graft after a grizzly bear
attack. The history, biology, mechanisms of wound healing,
indications/contraindications, clinical uses, dressing design, and the advantages
and disadvantages of maggot therapy are reviewed. The client included,
responded well to maggot therapy and the wound was prepared for the graft in a
short period of time.
Maggot therapy is an old form of treatment that needs to be considered by
more healthcare workers today for the treatment of non-healing wounds. If it
were to be introduced earlier in treatments, rather than after other treatment
techniques have failed, faster results may be gained.
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CHAPTER I
INTRODUCTION
The use of maggot debridement therapy to heal wounds was common
practice in the early 190.os in hospitals nationwide, however their use declined in
the 1940s with the emergence of antibiotic drugs, the improvement of aseptic
wound care, more aggressive surgical debridement techniques, and the
unacceptability of this therapeutic modality by the general public. 1,2 In recent
years, the use of maggot therapy has once again resurfaced as strains of
bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), have
evolved and become more resistant to certain antibiotics. 3 A study by Wolff and
Hanson,4 felt that maggots were responsible for altering MRSA into common
Staphylococcus aureus and then they healed the stubborn lower leg ulce·r.
The patient included within the case study presented with a right lower
extremity laceration as the result of a grizzly bear attack in Wyoming. This
accident occurred approximately two years ago and the information was obtained
from medical records and the hydrotherapy department at a Wyoming facility.
The soft tissue injury affected the gastrocnemius, extending down to the fibula,
and resulted in an infection.
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Problem Statement
Clinicians, as well as the general public, need to be more receptive to
alternate treatment techniques in wound care because conservative methods can
sometimes fail. Maggot debridement therapy is a natural form of treatment with
exceptional healing properties that needs to be further recognized an~ accepted.
Purpose of Study
The purpose of this study is to gain a better understanding of maggot
debridement therapy's history of use, biology, mechanisms of wound healing,
indications/contraindications, clinical use, dressing design, and the advantages
and disadvantages. In addition, a chart review of a patient who received this
form of treatment at a Wyoming physical therapy'facility will be included. The
case study will assist in better understanding the outcomes obtained with maggot
therapy and it will allow other wound care facilities to compare their maggot
therapy protocol to the one presented.
Significance of Study
The use of maggots is effective,however maggots are often used as a last
resort treatment and are used in few facilities today. Therefore, the material
presented in this study allows University of North Dakota physical therapy
students, physical therapists, instructors, other healthcare workers, and the
general public to gain a better understanding of all aspects of maggot
debridement therapy in one consolidated resource. By gaining a better
understanding of this technique through reviewing the literature and case study,
more health care workers may be receptive to their use and learn that positive
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results can be obtained through a nontraditiqnal treatment technique. If more
conventional measures of wound care are not working with specific patients,
maggot therapy should be considered. Maggot debridement therapy may be
more effective if it were to be used initially, rather than as a last resort treatment.
Research Questions
1)

What is the history of maggot debridement therapy?

2)

What are the mechanisms through which maggots help to heal wounds?

3)

How are maggots sterilized in the laboratory before they are used
clinically?

4)

How are maggots used clinically and what type of dressing design works
the best?

5)

What are some indications and contraindications for their use?

6)

What are the advantages and the disadvantages of maggot debridement
therapy?

7)

What results were achieved with maggot debridement therapy on a
specific patient at a Wyoming facility?
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CHAPTER II
LITERATURE REVIEW
History
Ancient surgical tools, pictographs, and fossilized bodies have proven that
wound care was one of the oldest forms of medicine practiced by man. 5 At that
time, science coincided with religion and superstitions and therefore some
wounds were seen as outward manifestations of evil. Treatments of these
wounds "involved making the body uninhabitable to demons, e.g. by beating,
starving, and torturing the patient.,,5(P47) As societies became more civilized, the
effects of certain medications on wound healing and specific treatment
techniques were introduced and studied.
The infestation of wounds with maggots has been recognized for several
centuries as well as the eventual treatment of necrotic wounds with fly larvae.
The earliest reference made to maggots can be found in the book of Job 7:5 in
the Bible. 6.7 "My flesh is clothed with worms and clods of dust; my skin is broken,
and become loathsome.,,6(p474) The majority of maggot infestations, however,
were observed on battlefields. Ambrose Pare has been credited as one of the
earliest to observe the beneficial effects of maggots on soldier's wounds. B
Soldiers during European wars and the Civil War were sometimes left to die on
battlefields with open wounds, but when found several days after their injuries
were inflicted and still alive, medical officers often found maggots residing in their
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dying tissues. In 1829 Baron Larrey, Napoleon's military surgeon, explained,
"these insects accelerated cicatrisation by shortening .the work of nature and by
producing an elimination of the necrotic cells by devouring them without
disturbing living tissue.,,9(p36) Joseph Jones, a medical officer in the American
Civil War quoted, "I have frequently seen neglected wounds .. .filled with
maggots ... as far as my experience extends, these worms only destroy dead
tissues, and do not injure specially the well parts.,,10(P1143) These wounds healed
faster than those without infestation and there were less deaths when compared
to soldiers being treated with the therapies of that time period . .
The first instance of therapeutically using maggots intentionally has been
credited to J.F. Zacharias, another Confederate medical officer in the Civil War,
in the 1860s. 1,10 He noted that maggots "in a single day would clean a wound
much better than any agents we had at our command" ... "1 am sure I saved many
lives by their use.,,10(P1143) However, the presence of infection caused by
anaerobic organisms such as Clostridium perfringens and Clostridium tetani
deterred the continuation of their.use at that time. 1 Finally in the 1920s, William
S. Baer performed the first clinical study of fly larvae. 11 Baer was an orthopaedic
surgical professor at John Hopkins Medical School in Baltimore, Maryland and
prior to his becoming a professor, Baer served as an orthopedic consultant to
U.S. forces in France.3,4 During World War I he treated two soldiers who had
been overlooked on the battlefield for almost a week after fighting had ceased. 3
The soldiers' wounds swarmed with maggots, however Baer recorded that the
wounds had new or granulated tissue in them and no signs of sepsis or infection
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was present. These observations during the war led to his studies and
treatments using maggots ten years later.
William S. Baer developed techniques on sterilizing maggots, designing
food sources for them, certain treatment techniques, and dressing designs. 11 In
his study, Baer used 89 patients with chronic osteomyelitis, a chronic
inflammation of bone and bone marrow, in a period when the mortality rate of an
open fracture in the lower extremity was at 75%. His subjects included both
adults and children. The results of his study showed a 90% success rate overall
with the total treatment time in children taking approximately six to seven weeks
and in adults taking approximately a third longer where other treatments had
failed. 11 ,12 Baer believed it took longer to heal adults because their new bone
formation is slower due to a lack of growing cells. 11 In adults, there are larger
amounts of dense bone present whereas the continual growing bone in children
naturally aids in the repair process. It may have also taken longer in adults
"because their osteomyelitis may have been present longer, therefore causing
more bone destruction and larger amounts of scar tissue formation. The results
of Baer's study are remarkable because many of his patients had tuberculosis or
other intractable infections. 12
Baer's study led to maggot therapy in the 1930s and 1940s in nearly 300
hospitals nationwide. 8,13,14 At this time, maggot therapy was used for abscesses,
burns, subacute mastoiditis, and osteomyelitis.1 5- 21 In the 1940s, however, the
use of maggot therapy declined for four major reasons: the introduction of
antibiotics, the improvement of aseptic wound care, more aggressive surgical
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debridement techniques, and the unacceptability of this therapeutic modality by
the general public. i ,2
The use of maggots once again resurfaced in the 1990s with the
emergence of multiresistant strains of bacteria such as Staphylococcus aureus,
which have caused antibiotics to be ineffective. 3 Infected wounds that contain
devitalized or necrotic tissue may not respond to antibiotics because the agent in
the bloodstream is unable to reach the dead tissue secondary to an ineffective
blood supply to that area. Antibiotics also do not facilitate wound debridement
and may even retard the process if they inhibit or kill the activity of nonpathogenic proteolytic bacteria, which naturally aid in the reduction of necrotic or
dead tissue. In contrast to antibiotics, maggots remove both. necrotic tissue and
bacteria , leaving. a healthy granulating wound .
Life Cycle
Lucilia and Phaenicia both comprise the common greenbottle blowflies. 8
The adult fly is a metallic coppery-green color hence its common name, the
"greenbottle" blowfly.3 The word "blow" means to lay eggs and the word "bottle"
is believed to be a form of the word "bot", an ancient word for maggot. 8 It is
important to understand the life cycle of this particular species of fly when using
them as a form of treatment (Figure 1).
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Eggs
Pupa

~
Figure 1. Life cycle of the blow fly
(Adapted from Sherman RA: Maggot therapy project. Available
at: http://www.ucihs.uci.edu/path/sherman/homepg.htmi
1995)

The adult green bottle fly lays large numbers of eggs in clusters or what
are known as "rafts".3.22 The larvae hatch from the eggs within 12 to 24 hours
and are 1 to 2 millimeters in length (Figure 2). The larvae reach maturity within 4
to 5 days, however this number varies depending on temperature, and are now
approximately 8 to 10 millimeters in length, approximately the size of a piece of
rice (Figure 2). At this time, they stop feeding and look for a place to complete
the next stage of their development. The larvae form a puparium, which is
produced from hardened skin. Within this new structure, the larva undergoes
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metamorphosis and transforms into an adult fly within seven days. Once the
adult fly has hatched, it feeds, mates, and then produces its own eggs and the
cycle begins again . In addition to understanding this species life cycle, it is' also
important to understand its mechanisms in wound healing.

Figure 2. Approximate Size of maggots before and after
Debridement. (Photo by Ronald A. Sherman, University
of California). (Reproduced by permission from Sherman RA:
Maggot therapy project Available at:
http://www.ucihs.uci.edu/path/sherman/homepg.htm. 1995)

Mechanisms of Wound Healing
Several different theories have been suggested regarding how maggots
cleanse and heal wounds. These include:
1) Liquefaction of necrotic tissue by the secretion of proteolytic
enzymes 23 ;
2) Digestion of necrotic tissue and microorganisms as food by
larvae 23 ,.
3) Mechanical washing out of bacteria by the serous exudate
caused by the irritating effect of maggots in the wound 8 ;
4) Change in the wound r.H from acidic to alkalitic as a result of the
formation of ammonia ,11,24;
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5) Formation of granulation tissue resulting from mechanical
stimulation of viable tissue caused by the continuous crawling of
the larvae 21 .,
6) Intrinsic factors within the maggot causing growth-stimulating
effects 25 .
7) Destruction of bacteria by antibacterial substances (allantoin).2628

Proteolytic enzymes are endogenously produced proteins that breakdown
necrotic debris resulting from cell breakdown.29 These enzymes, whose
activation is precisely regulated, serve many functions in normal situations as
well as those situations which are pathological. Proteolytic enzymes are involved
in the regulation of cell maturation and multiplication, collagen synthesis and
turnover, the development and removal of the perivascular fibrin cuffs found in
venous insufficiency and leg ulceration, and the removal of dead tissues after
inflammation. It is believed that maggots produce a powerful mix of proteolytic
enzymes, which cause a liquefication of the necrotic tissue inside the wound. 3D
The liquefied substances are ingested as well as possibly absorbed through the
maggot's integument to be used as a food source. 31 A study by Sinclair and
Ryan 29 researched the use of synthetic proteolytic enzymes being used topically
as a form of treatment in wound care. Because most topical agents do not seem
to penetrate the entire depth of wounds, one consideration of this experimental
treatment should be whether or not this cream has the ability to reach desired
targets and depths.
A study by Vistnes, Lee, and Ksander3D on the proteolytic activity of the
blowfly Calliphora erythrocepha/a larvae, involved the effects of larval secretions
on experimental burns. It was shown that the secretions of these larvae digested
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the eschar on the burned skin of experimental rats in vivo (on the living
organism) and in vitro (in a test tube) when applied as a topical cream. The
burns treated with larval secretion cream were further debrided than the burns
treated with regular cream, proving that larval secretions could be a potential
agent for the removal of burned, necrotic tissues.
Wound pH and the presence of ammonia is another theory as to how
maggots heal wounds. When maggots feed on meat, animal debris, and
wounds, the odor of ammonia develops.24 A study by Robinson and Baker,24
reviewed whether or not the ammonia found in wounds was produced by the
maggots themselves or by the bacteria, which naturally reside in their digestive
tract. Urea, one of the final products of protein metabolism, is found in blood and
lymph, and therefore is present in human as well as all animal tissues. 24 ,32 The
enzyme urease is also found in several organisms including bacteria, fungi,
plants, and animals. 24 Enzymes are proteins that change the rate of a chemical
reaction. 32 The ammonia is formed when the enzyme urease comes into contact
with urea to break it down.24 The study by Robinson and Bake~4 proved that
urease is present in both the excretions and tissues of Lucilia sericata (sterile
and non-sterile larvae), the species of blowfly used in wound care today. The
urease that is present in the maggot excretions comes into contact with the urea,
which is present in the wound bed of the patient. Ammonia is formed by the
joining of these two substances and therefore produces an alkaline environment
inside the wound. William S. Baer and others have proven that "wounds with an
alkaline reaction healed faster than those inclined to be acid.,,11,24(p149) Baer
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noted that most wounds have an acid reaction but once the maggots were
introduced into a wound, it took only about 24 hours to become alkaline. 11 He
believed alkaline wound beds caused sterilization of the wound and the killing of
any bacteria present.
Another theory as to how maggots heal wounds, involves the possible
secretion of growth factors by maggots. A study by the Department of Veterans
Affairs Medical Center in Long Beach, California 25 researched the growth effects
of Phaenicia sericata larval extracts on fibroblasts. This study exposed human
fibroblast tissue culture to hemolymph (blood and lymph) as well as alimentary
extracts from the maggots. The growth effects of maggot extracts were
compared to those of epidermal growth factor, recombinant interleukin 6, and the
insect hormone 20-hydroxyecdysone. This study found that maggot extracts
stimulated significant increases in human fibroblast numbers, therefore
suggesting that maggots have intrinsic factors that might be responsible for the
growth stimulating effects seen in wounds infested with maggots. The release of
these growth factors by the maggots may be responsible for the stimulation of
new granulation tissue. 33 However, the stimulation of newly granulated tissue
may also be due to the constant movement of the maggots within the wound. 1
One final theory as to how maggots debride wounds and promote wound
healing includes the destruction of bacteria in the wound through excretions,
which contain antibacterial substances. A study from 1934 by William
Robinson 26 determined that urinary excretions from both sterile and non-sterile
maggots contain allantoin. Allantoin is the principle terminal product of purine
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'metabolism and results from the oxidation of uric acid. It not only is found in
maggot urinary secretions but also is common in plants and animals. The
allantoin for the study was obtained commercially and was applied to ulcers,
burns, and wounds with little granulation. Local granulation was found where the
allantoin was applied after just a few treatments.
It has been researched that several other species of insects possess the
ability to produce antibiotic-like agents. 34 Studies on the screw-worm, a species
not used in maggot therapy, suggest that antimicrobial agents including
phenylacetic acid and phenylacetaldehyde are formed by the bacterium Proteus

mirabilis. Proteus mirabilis naturally resides in the gut of the screwworm and it is
believed that the bacteria remaining in the wound bed, which are not ingested,
are killed by chemicals produced by this bacterium. 35 This bacteria may be the
one responsible for the killing of the bacteria in the wound bed.
There are still many unanswered questions as to the exact mechanism
,that maggots use to cleanse and heal wounds. It may only involve one of the
theories listed above or it may be a combination of several.
Maggot Sterilization
The purpose of using maggots in wound care is to clean out any existing
infection and/or necrotic tissue therefore, it is important that the maggots be
sterile so they do not introduce additional bacteria. Sterile medicinal maggots
indicate that the maggots to be used in therapy are "disinfected" or free from
bacteria. 36 Although sterile, maggots are still capable of maturing into adulthood,
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however it should be remembered that maggots are sexually immature and are
incapable of reproduction until they have pupated into adult flies .
William S. Baer was the first to clinically study maggots and he was the
first to develop a process in sterilizing them in the laboratory.11 Initially Baer
attempted to sterilize the maggot itself rather than the egg. Through several
trials, he found that the intestinal tract did not become sterilized with this method
and that is where some bacteria reside in the maggot. This method did not work
because only the external surface of the maggot became sterilized and not the
inside. Baer decided that the egg must be sterilized in order for the process to
work. The test tubes used to house the eggs were sterilized in hot air at 160°C
for one hour. The eggs were then divided and placed into

di~erent

test tubes.

Next, the sterilizing solution of ethyl alcohol, hydrochloric acid, and mercury
bichloride was poured over the eggs in the test tubes. The eggs were immersed
in this solution for a total of thirty minutes. In order to wash the eggs, they were
first strained with gauze and then sterile distilled water was poured over them.
Finally, the eggs were transferred to bottles that contained sterile food. The
sterilized food consisted of agar culture media liquefied, Fleischmann's yeast,
and pig liver. The liver was chopped up into cubes, covered with water, and was
allowed to boil for twenty minutes. The yeast was added to the liquefied agar
and then was poured over a cube of liver inside a bottle. The bottles, each
containing a cube of liver, were then sterilized for thirty-five minutes at fifteen
pounds' pressure. Next, the bottles were incubated at 37° C for thirty-six hours
and then were sterilized again for the same amount of time and pressure.
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Today, different companies have different methods of sterilizing maggots,
but all include methods similar to Baer's method of sterilization. One method
included in an article by Teich,37 involved washing the eggs three times with
water after removing them from their food source. The eggs were then sterilized
with three washes of a solution of sodium hypochlorite (Clorox) diluted 1:50, and
then they were hatched in a sterile flask.
A study by Sherman and Wyle 38 stated that they disinfected their eggs by
washing them for five to six minutes with 3% Lysol and then three rinses with
sterile saline. The eggs were then separated from one another by soaking them
in sodium sulfite or sodium hypochlorite. They believed it was crucial to
individually separate the eggs from one another before disinfection because
otherwise bacteria can become trapped within the egg masses and the
disinfectant will not penetrate this area. Baer also believed the separation of
eggs was necessary before pouring the sterilizing solution over them and he
separated the eggs by stirring the eggs in water.11 Next, they placed the hatched
maggots in a sterile container that contained the food source of sterile raw
chicken.38
A study completed by Mumcuoglu et al 2 "surface sterilized" their maggots
with 1% sodium sulfite in physiological saline that contained 2.5% formaldehyde.
Next, the eggs were transferred to a container that consisted of a mixture of
pureed liver, and agar containing kanamycin monosulfate. After hatching, the
larvae were washed with sterile distilled water. After washing, they were surface
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sterilized again with 3.5% formaldehyde in physiological saline, washed with
distilled water, filtered through a sieve, and stored in sterile Eppendorf tubes.
In order to make sure their sterilizing process was successful, some'
facilities that raise maggots have their maggots cultured in a laboratory before
they are sent off for use in clinics. 39 The facilities that raise the maggots may
have their own laboratory equipment ·available for culturing or they may send the
maggots to be sampled at a local hospital.
Indications and Contraindications to Maggot Therapy
Today, a majority of patients treated with maggot therapy have ulcers,
pressure sores, or traumatic wounds which have become infected. These ulcers
include diabetic foot ulcers (arterial ulcers), venous stasis ulcers, and other
neurovascular ulcers.39 Ulcers can develop, for example, in patients with
diabetes who have poor circulation.

Pressure sores develop in patients who

have been bed-ridden for extreme periods of time and therefore their blood
pools. Poor circulation or pooling blood can lead to tissue cell death and
therefore necrotic tissue develops. Maggot therapy is also used for patients who
require pre-surgical debridement and for those patients with post-surgical
wounds that are not healing with other forms of wound treatment. 39 It can also
be used for osteomyelitis,11 as Baer researched years ago, as well as for any
gangrenous tissue. 39 Gangrene is the death of tissue cells secondary to the
blockage of blood supply to a wound and if it is not removed, the tissue will rot. 40
Maggot therapy is also indicated for wounds that have antibiotic resistant strains
of bacteria like methicillin-resistant Staphylococcus aureus.41 Other uses have
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included cellulitis, mastoiditis, abscesses, cancerous tumors, and recently
maggot secretions have been used to treat burns. 9 ,21,23,3o In cases where maggot
therapy was used to treat cancerous tumors, it should be noted that maggots
cannot be used as a cure for cancer but studies do indicate they may decrease
tumor size or can be used for palliative care. 3
Maggot therapy is not appropriate for all patients and certain
contraindications should be considered before its use. Maggot therapy should
not be used on wounds that bleed easily and they should not be placed in
wounds that are located near large blood vessels or those associated with a
body cavity or organ. 39 One final contraindication involves the psychological
status of the patient. If the patient is unable to handle the idea of maggots as a
form of therapy, then they are not a candidate for this form of treatment.
Clinical Use
The species of fly larvae used clinically today is Phaenicia Sericata (green
blowfly) or Lucilia sericata. 3 ,39 Any licensed physician can prescribe maggot
therapy in the clinic, but most commonly, plastic surgeons or orthopedic
surgeons will order their use. Some physicians apply the maggots themselves,
but physical therapists, nurses, nursing assistants, and even entomologists can
apply them. 22 The patient will have consented to their use prior to beginning
treatment and they will be informed on their use and what is expected with this
form of therapy.
Prior to applying maggots in the clinic, the size, shape, amount of exudate,
and the odor of the wound should be recorded. It is important to measure the
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wound's length, width, and depth as well as the amount of necrotic tissue and
newly granulated tissue present. Sometimes wounds are traced onto a sterile
plastic sheet with a grid to keep in the patient's chart. The number of maggots
that should be introduced into the wound is dependent on the wound's size. 3 A
general rule is that no more than ten maggots per centimeter squared should be
applied to a small wound and even less if there is a smaller amount of necrotic
tissue present.
The maggots arrive in a sterile container with a Iid. 39 The lid contains a
filter that allows air to enter but not microorganisms. They are usually ordered in
units and one unit contains approximately 1000 maggots at a price of
approximately $80. Within the sterile container, there is a 4 x 4 soaked with
nutrients to provide a moist and somewhat humid environment. Occasionally
upon arrival some of the maggots may have dried up and died and will look like a
black speck. Most companies who supply facilities with maggots will ship them
overnight for next day delivery. It is generally a good idea to use the maggots
within one day after their delivery, but if they are not used immediately they can
be kept up to five to seven days if properly stored in a refrigerator at or slightly
above 5 to 6 cG. While refrigerated, a moist gauze pad should be placed in the
container every so often to keep them moist so they will not dry out. The maggots
should also be removed from the refrigerator twice a day for one hour to prevent
them from freezing. The application technique and the dressing design vary
among facilities and the company who provides them.
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To apply maggots to the wound, the maggots can be swiped from the vial
onto a saline-soaked 4 x 4 pad and then loosely pack the 4x4s into the wound
bed. The gauze application of the maggots allows for easy handling of the
maggots and gives the maggots a "larger area through which to crawl before
reaching the wound margins and escaping.,,42(P453) Another method to remove
the maggots from the vial is to pour a small amount of saline into the vial with the
maggots.39 Swirl the saline around in the vial to loosen the maggots from the
sides of the vial. Then, strain the vial contents over a piece of chiffon, remove
the maggots from the chiffon with a tongue depressor and then place inside the
wound. Once the maggots are placed inside the wound bed, the maggots have a
tendency to congregate together and they use their mandibles to latch on to the
necrotic tissue on which they will feed .3 Next, the dressing is applied to the
wound and includes a "cage-like" design. The dressing should not only contain
the maggots, but also allow oxygen to enter and the liquefied necrotic tissue
produced by the maggots to seep

OUt.

42 The maggots are left in place anywhere

from 24 to 72 hours.39 If the larvae are left in the wound longer than this amount
of time or after they are satiated, the next stage of development (pupation) will
OCCUr.

36 ,42 If the maggots try to pupate within the wound they will do so in either

the tissue itself or in the gauze that is inside of the wound. 36 If the dressing
becomes loose during the treatment time, then the edges of the dressing should
be taped down with a hypoallergenic tape to prevent further escaping. 39 If the
entire dressing comes off, then the patient should come in to the clinic and the
process of application should be repeated.
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After 24 to 72 hours, it is time to remove the maggots from the wound. A
red biohazard bag should be placed next to the wound, or if it is an extremity,
within the bag itself. The dressing is removed and the wound is rinsed with a
bottle of saline. By rinsing the wound into the bag, the maggots and dressings
are quickly and properly contained and environmental services can be contacted
to properly dispose. It is not recommended to use a whirlpool or Hubbard tank
for the removal of the maggots because the maggots can get into the whirlpool's
agitator. This would make it hard to clean and the chemicals used in cleaning
the whirlpools may not kill the maggots thoroughly. Once the dressing is
removed, the 8 to 11 mm maggots now full of food, may be seen feeding in the
"head down" position and tunneling tracts may be noted. 3 The amount of necrotic
tissue will determine the number of sessions needed with maggots, as ordered
by the patient's physician. 39 Nearly half an ounce of dead tissue can be digested
each day by the average dose of maggots. 43 The process of therapy may need to
. be repeated once or twice a week or until the wound is healed. Sometimes one
session is sufficient, whereas wounds with large amounts of necrotic tissue may
need several weeks of therapy.3 Indicators that maggot therapy should be
discontinued are a decrease in wound odor, decreased wound drainage, and
healthy red granulating tissue in place of the necrotic tissue. 39 A majority of
clinics discharge maggots when the-wounds are free of necrotic tissue, however
William S. Baer continued their use until the wound was completely filled with
granulation tissue. 11 By extending the maggot's use, re-infection with bacteria
may be prevented as well as the build-up of sloughy debris. One clinic noted that
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the maggots have a tendency to leave behind a "silvery-slimy tissue" that they do
not want to ingest. Because of this, it is necessary to use another form of
debridement in addition to the maggots. In Baer's study,11 it was felt that a
"scum" left over the newly granulated tissue may be due to Proteus bacillus, a
persistent bacteria that remained in the wound.
Dressing Design
The maggot therapy dressings used 60 years ago were rather elaborate,
time consuming, and expensive. 42 Today, the types of dressings used in maggot
therapy will vary among facilities and the materials available. Most facilities find
that dressing design is a process of trial and error and is a technique learned
from mistakes. Selection of the dressing is an important part of this type of
treatment and several things should be kept in mind when designing the
dressing.
The dressing should be "cage-like" in order to keep the maggots from
escaping the wound bed throughout the course of treatment. It is important to
keep the maggots within the wound because they may leave the wound once
they are full or when it is time to bury themselves for pupation, the next stage in
their development. 42 The dressing should allow oxygen to enter the wound bed
but at the same time should absorb liquefied necrotic tissue that the maggots
have produced . The dressings should be easy to apply, simple to maintain,
durable, and inexpensive. Sometimes the powerful proteolytic enzymes that the
maggots secrete cah be irritating to healthy tissue causing the surrounding tissue
to become red and this should be considered when constructing a dressing
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design in maggot therapy.3 This redness may be due to the maggot secretions
or it may be a bacteria present on the wound borders that is not visible to the
therapist but is recognized by the maggots.
One type of dressing design suggests surrounding the wound with
DuoDerm, a type of hydrocolloid dressing, and then applying a layer of Mastisol
over the DuoDerm.39 DuoDerm provides a moist healing environment, however
maceration may occur with large amounts of wound exudate. 44 After the
maggots are placed inside the wound, a piece of chiffon, larger than the wound,
is put in place over the DuoDerm.39 The chiffon is secured with another layer of
.Mastisol followed by DuoDerm. Next, a 4 x 4 is placed over the previous, or if
the wound is on an extremity, a Kerlix roll can be used to hold everything in
place.
Another dressing design that may be quicker than the previous, fits a
piece of Derma-net over the wound bed once the maggots are in place. The
Derma-net is edged with Hypa-fix tape, a cloth-like tape, to prevent maggots from
escaping the edges of the dressing. Next, an ABO pad is put into place and then
burn net is used to hold the entire dressing in place.
Other designs have been made using hydrocolloid dressings and zinc
paste bandages to better contain the maggots. 3 Sometimes, hydrocolloid
dressings cannot be used because of a wound's location or if the patient has
overly sensitive skin. In this case, a zinc paste bandage can be used in place of
the hydrocolloid. A dressing design that uses hydrocolloid, described cutting a
piece of hydrocolloid to fit the wound size. Next, a sterile piece of fine nylon
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mesh was cut larger than the wound size but smaller than the al"ready cut
hydrocolloid dressing. The nylon mesh was taped to the back of the hydrocolloid
dressing. To cover the hydrocolloid, an absorbent pad was put in place to
absorb any exudate from the wound. This outer absorbent pad is beneficial
because it can be changed without disturbing the primary dressing.
A study by Ronald Sherman 42 described his "most successful" dressing
design (Figure 3). This technique first applied DuoDerm directly to the skin
surrounding the wound with a hole cut in the center of the dressing to surround
the wound. Next, two coats of Skin Bond Cement were spread over the
DuoDerm. The maggots were then introduced to the wound through the opening
that was cut into the center of the DuoDerm. A sterilized piece of chiffon was
placed over the DuoDerm and wound bed and was glued in place with the
cement.

Next, silk tape was placed along the chiffon to further adhere the

chiffon to the' DuoDerm. Finally, a transparent ring of semipermeable membrane
sheet was placed over the silk tape and over part of the surrounding skin. A
semi-permeable membrane film is a transparent tape-like substance. It is
permeable to moisture vapor and oxygen but not to bacteria and water. 44 This
final layer was put into place to help protect the dressings from soiling and to "act
as an effective second-line barrier to the occasional maggot that managed to
navigate between the skin and the DuoDerm.,,42(p453) A final gauze pad was
placed over this entire design to absorb any drainage produced from the wound
and could be changed every so often as needed . If the top gauze pad were left
in place too long, it would become too moist from excessive exudate and would
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cause the dressings below to loosen. This study proved this dressing design to
be very successful and reduced the frequency of maggots escaping to less than
one percent of all maggot dressings applied . The average length of time to apply
this type of dressing was approximately 30 to 45 minutes. Although this dressing
design is time consuming, the prolonged survival rate of this dressing and the
reduced frequency of maggots escaping "have more than compensated for the
extra effort required to construct it.,,42(p454) This dressing design is also worth the
time in its construction because it allows the wound bed to be directly observed
throughout the patient's treatment. One disadvantage of this dressing design
would be that if a large number of maggots were introduced to the wound and the
dressing was applied too tight, pressure damage could result. If the wound is
located in an area where a hydrocolloid ring or a sheet of chiffon are unable to be
used, then a nylon stocking can be applied. The stocking has the advantage
over the chiffon of stretching, therefore allowing the wound to expand. Sherman
also found that by coating the surrounding skin of the wound bed with a skin
protectant like Shield Skin, the tissue was less likely to become inflamed and the
adherence of the DuoDerm was also improved.
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SEMI-PERMEABLE
TRANSPARENT
DRESSING

G l U E-----;r"--

MAGGOTS
ON GAUZE

Figure 3. Optimal maggot debridement therapy dressing design
(Reproduced with permission by Sherman RA: A new dressing design
for use with maggot therapy. Plast Recontr Surg. 100:451-456, 1997)

. A study by Thomas and Andrews,45 examined the effects of hydrogel .
dressings on maggot development. Hydrogels are "three-dimensional, waterswollen, cross-linked structures" which have the "ability to absorb or donate fluid,
depending on the nature of their formulation and the state of hydration of the
wound.,,45(p75) They are thought to "promote autolytic debridement by increasing
the moisture content of slough and necrotic tissue, thus facilitating enzymatic
activity.,,45(P75) This study was made because many times maggot therapy is
used as a last resort treatment method and therefore traces of other products in
the wound are left from prior treatment methods. It was believed that certain
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brands of hydrogel were having effects on the development and survival of the
larvae in the wound. The study examined the effects of six different brands of
hydrogel: Aquaform, Granugel, Intrasite, Nugel, Purilon, and Sterigel.

Fresh

pig liver was blended with different percentage amounts of the six different
brands of hydrogel. Next, the larvae were introduced to each sample and left to
feed on the liver for 48 hours. At the end of the 48 hours, the larvae were
counted and weighed. All the gels but one contained propylene glycol, therefore
it was necessary to carry out a second study to determine the effect of this
substance on larval survival and development. Propylene glycol is added to gels
in order to prevent the gels from drying out and also to prevent the growth of
microorganisms.
The studl 5 found that there was reduced larval growth and there also was
an increase in the mortality of the larvae with increased concentrations of
Granugel, Intrasite, Nugel, and Sterigel. With Aquaform, this trend was reversed,
however there still was a decrease in larvae development when compared to
control values. Purilon gel was found to increase the development of larvae
when compared to control values and this is believed to be true because of the
absence of propylene glycol. When propylene glycol was added to the
liver/Purilon gel mixture in the second part of the study, there was a marked
decrease in the development of the maggots. When propylene glycol was added
to the liver alone, an even further decrease in larval development was noted.
This study also found that when water was added to both the liver/gel mixtures
and to the liver alone, the larvae survival and growth rates decreased. It should
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be remembered that maggots feed by secreting enzymes which dissolves any ·
dead tissue, turning it into a "liquid soup", which makes for easy ingestion. "In
the presence of excess liquid, it is postulated that, if the maggots do not drown,
their digestive enzymes become diluted and therefore rendered less
effective. ,,45(p77) "The increase in larval development observed with increased
quantities of Purilon gel may be attributed to the ability of the gel to absorb
excess fluid from the blended liver, resulting in the formation of an increasingly
cohesive mass.,,45(p77) Like the Purilon gel, Aquaform also reduced the fluidity of
the macerated liver and this decrease in water content may be responsible for
the increased survival rate of the maggots. This study would be important for
health care workers using maggots to keep in mind if they fee.! they are not
getting the results usually presented.
Patient Education
Patient education is crucial in any type of healthcare, especially in physical
. therapy. When first explaining to a patient that maggots are going to be used for
treatment, most patients have mixed feelings. It is critical that the patient
understands the entire process of maggot therapy prior to initiating their
treatment. 3 It is also important to show the patient the actual size of the maggot
to be introduced to their wound. Most facilities have a brochure or video on
maggot therapy that is reviewed with the patient prior to beginning treatment.
Begin by explaining the type of maggot to be used in treatment and the
mechanism of their wound healing process. All species of maggots are not
identical in their actions. Some burrow into healthy tissue, while other species
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digest only necrotic tissue. 22 Explain that the maggots are sexually immature,
are disinfected, and that they will be removed before it is time for the next stage
in their development (pupation).36 Also explain that the maggots will not enter
their bloodstream while inside of the wound bed. Let the patient know that they
may feel the maggots moving around inside the wound, a tickling sensation, but
that it is normal. 46 This tickling sensation can be a downside to maggot therapy,
however a majority of patients treated with maggots have diabetes and therefore
have poor sensation in their extremities. The odor during this form of therapy
can be quite offensive the first few days because the maggots have stirred up the
bacteria in the wound. 11 Odor should decrease as the treatments progress
because the maggots feed on the bacteria causing the tissue: death. Sometimes
a wintergreen spray is given to patients to spray on their outer bandage to help
mask the strong odor. Patients will also be concerned with whether 'or not
treatment will be painful. Explain that a majority of patients feel that their wound
pain is reduced or completely eliminated during maggot therapy.3 Cost is
another big concern of patients and they should understand that maggot therapy
is generally cost effective.
Most healthcare workers, who have used maggot therapy as a form of
treatment, have found patients to be remarkably tolerant of their use. 46 As a
health care worker who is providing this type of treatment, it is important to act
confident with what you are doing. 43 If the patient senses you are uncomfortable,
they will be uneasy with treatment as well.
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Advantages and Disadvantages of Maggot Therapy
The advantages of maggot therapy outweigh the disadvantages and with
an increase in resistance of certain types of bacteria to antibiotics, clinicians
nationwide need to consider alternative methods of wound management.
Although sterilized maggot treatments can be costly, this treatment is cost
effective in the end. 3 For example, a 72-year old man diagnosed with bilateral
chronic foot ulcers located on his metatarsal heads was treated for twelve
months with conventional measures. 12 These conventional methods included:
silver sulfadiazine cream 1%, saline dressings, unna boot therapy, topical
enzymes, topical antibiotics, intravenous antibiotics, sodium hypochlorite 0.5%,
hydrocolloids, hydrogels, foams, and calcium alginate dressings. After twelve
months, no signs of healing were noted. This patient was then entered into a
maggot therapy study in 1993 where the left foot was to receive maggot therapy
twice a week and the right foot was to continue with the conventional

met~ods

of

treatment. By the fourteenth week of the study, the left ulcer was almost
completely healed where the right ulcer remained unchanged. This specific
study reveals how maggot therapy is cost effective because of decreased
treatment time in the clinic. Maggot therapy is also cost effective because it can
be done as an outpatient; therefore the patient does not have to pay for overnight
stays or nursing fees and may even prevent a costly amputation. 33
Another advantage of maggot therapy is that it takes less time than
surgical debridement and the healthy tissue is not damaged. Surgical
debridement is a type of semi-selective debridement meaning that both necrotic
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and living tissues are removed together, ideally more necrotic tissue being
removed than viable tissue. 44 Maggot therapy is a type of selective debridement,
meaning only necrotic tissue is removed. Therefore selective debridement is
much more advantageous than semi-selective debridement.
Other advantages of maggot therapy are that no anesthetic is necessary
and it is less painful than other methods of debridement. 47 Maggots also do not
require an excellent peripheral blood supply,31 which is beneficial for patients with
diabetes. The maggots also may actually initiate new tissue growth by secreting
growth promoting agents. 21 ,25 Maggots are also universally available. 31
One of the main disadvantages of maggot therapy is aesthetic in nature.
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It is hard to convince some clinics and patients to use maggots because they are
often associated with dirt, decay, and/or death.3 On a recent episode of an
emergency room television series, a patient with gangrene was being treated
with maggots 30 mm in length, causing the patient to become hysterical. It is no
wonder that patients, as well as clinicians, are skeptical about their use when the
actual average size of maggots used in therapy is 2-3 mm in length. Another
disadvantage may include a localized pruritis, or itching, however most patients
are unaware of the maggots presence. 31 A skin irritation may also develop
secondary to the strong proteolytic enzymes released by the maggots. 3 A
summary of the advantages and the disadvantages are listed in Table 1.
As of today, maggots are generally used as a last resort treatment method
for stubborn wounds that will not heal. After weighing the advantages to the
disadvantages, it is clear that maggots should become a regular form of
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treatment in wound care facilities worldwide . . If maggot therapy were to be used
earlier in treatment in place of conventional methods of wound care, it could
become even more effective in results and in controlling costS.47

Table 1. Summary of the advantages versus the disadvantages of
maggot debridement therapy

•
•
•
•
•
•
•
•

Cost effective
Selective debridement
Can Rx as outpatients
No anesthesia necessary
Less painful
Universally available
Good peripheral blood
supply not necessary
May initiate new tissue
rowth

•
•
•
•
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Aesthetic in nature
Localized pruritis (itching)
Patients may feel their
crawling/tickling
Leave behind a silvery,
slimy tissue

CHAPTER III
METHODOLOGY
Instrumentation ·
Two databases were used to locate journal articles pertinent to this study.
Medline is a database that includes articles from international biomedical journals
of all languages and includes publications from 1966 to the present. A majority
of the references used for this study were located using this database at the
Harley E. French Library of the Health Sciences, University of North Dakota.
Infotrac's Health Reference Center was another database used at Coe Library,
located at the University of Wyoming. For journal articles that were not available
at the University of North Dakota, interlibrary loan was used. The Internet was
also useful in locating articles and pictures of maggot debridement therapy.
In addition to the databases and Internet, a company that supplies the
Wyoming facility included within the case study with their maggots was contacted
with a phone call. This company, biomaggot.com, Inc., provided a pamphlet of
information regarding maggot therapy and how to use their product clinically.
Interviews with a physical therapy assistant who works in the hydrotherapy
department were also made on several occasions to answer questions as they
arose throughout the research process. Observation of the application of maggot
therapy to a patient was made possible at the hydrotherapy department. This
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treatment was applied to a patient other than the one included within the study,
however through this observation, the application technique was further
understood.
Procedure
A physical therapist at the Wyoming facility's hydrotherapy department
was contacted with a letter describing the proposed project by the researcher. A
phone call was also made to the medical records office at this same facility.
Once the University of North Dakota's Institutional Review Board (IRB) approved
the proposed project, a copy of it was given to the medical records office. This
proposed study was presented to the hospital's lawyer and permission was
granted. Both departments were willing to participate once permission was
approved. Because the copying of any clinical photographs taken in
hydrotherapy was not included within the original proposal, a memo was sent to
the University of North Dakota to inform them of the change. The University
permitted the changes and a copy of the signed memo supporting the change
was given to the medical records office. While all of the paperwork was being
processed, articles were

gathe~ed

from the two databases.

Once all of the paperwork was cleared, copies were made from the
subject's chart in medical records at the Wyoming facility. Copies of the subject's
initial hospital notes (where the subject was first admitted immediately following
the accident), EMS reports, radiology reports, surgical reports, physician's
orders/evaluations/discharge notes, and physical therapy/hydrotherapy
reports/notes were made. These copies were reviewed to gain an understanding
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of the subject's accident and the medical procedures performed after the
accident occurred. The subject was contacted and informed of the study and the
subject provided informed consent for the release of medical records and any
photographs taken in hydrotherapy. The subject was contacted with questions
that could not be answered after the chart was reviewed. Copies of the
photographs taken in hydrotherapy were made after patient consent and were
helpful in viewing the progress made in hydrotherapy.
Subject
Selection
One subject, who underwent maggot debridement therapy at a Wyoming
facility two years ago, was selected for this study. The subject provided written
consent to allow the review of his chart at the Wyoming facility's medical records
office (Appendix). The subject also provided written consent to allow copies to
be made of photographs taken en the hydrotherapy department at this Wyoming
. facility.
At the time of the intervention, the subject was in good physical condition,
had a non-significant past medical history, and had no coexisting medical
conditions that would interfere with his hydrotherapy treatments. This subject
was recommended by the hydrotherapy department because of the positive
results achieved through maggot debridement therapy, his good physical and
mental condition, his local residency, and because no other coexisting medical
conditions interfered with his treatments. A majority of patients treated in
hydrotherapy are elderly and have coexisting medical conditions that sometimes
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interfere with their treatments and on occasion death precedes the completion of
their treatments. Because the subject lives locally, any needed information could
easily be obtained if questions came about.
The hydrotherapy department initially contacted the subject by phone to
see if he would be willing to release his medical information for the inclusion
within the study. The department gave the subject the researcher's phone
number and contact was made that day. A meeting with the subject was
necessary so the study could be described in detail prior to informed consent and
the consent form could be signed.
Client History
The patient was a 40 year-old white male who works fulltime, enjoys
outdoor activities, and is married. He has a past medical history of seizures and
a left medial collateral ligament (MCl) repair with screws in 1976 and his
medications at this time were not significant.
The patient was camping alone in a Wyoming park when he encountered
a grizzly bear. The bear bit him on the right lower extremity, scratched him on
the abdomen, and threw him into the air before being driven off with pepper
.spray. The patient had to hike out of the park alone and then he drove by himself
for several miles to a nearby hospital. Upon examination in the emergency room,
it was evident that the patient had sustained a huge laceration to the right lower
extremity. The wound extended from the proximal tibia in a semi-circular fashion
to the distal one-third of the lateral tibia, resembling an "s" shape. The wound
extended through the gatrocnemius muscle down through to the fibula. Neither
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foot drop nor decreased sensation was present. The peroneal nerve and the
vasculature to the leg were all intact and normal. X-rays of the right lower
extremity revealed no fractures or osseous deformities, however significant
amounts of gas were present as well as soft tissue swelling secondary to the
laceration. The bear claw scratches to the abdomen were superficial and did not
present a problem. While in the hospital, the patient received surgery the day of
the accident. The wound was debrided and a pulse lavage was used to irrigate
the wound bed. The loose flaps of skin were approximateq with sutures and a
drain was put into place. Several 4x4s soaked with Betadine, an anti-infective,
were applied to the wound along with a leg splint. The following day, further
debridement was performed in the operating room along with pulse lavage and
the wound was once again partially closed with sutures. Betadine 4x4s were
applied along with Kerlix gauze rolls and an Ace wrap. In addition to the two
surgeries, a tetanus vaccination was administered at this facility.
Two days after the accident, it was felt that the patient was strong enough
to travel via private vehicle to a larger hospital located in the patient's hometown.
En route to the larger hospital the wound began to hemorrhage and an
ambulance was called to intercept the vehicle and complete the trip . . In the
ambulance the patient was put on oxygen, a pressure dressing was applied, and
the lower extremity was elevated. Upon arrival at the second facility, the patient
was given one unit of blood and pain medications. The examination at the
second hospital revealed that the wound flap, which had been sutured at the
initial hospital, was slightly bluish in color and the wound bed had a slow capillary
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refill. No purulent discharge or odor was present at this time. Because the skin
flap was necrosing, it was anticipated that a split-thickness skin graft (STSG)
would be necessary in the future. The physician predicted that there would be
complications with infection because grizzly bears are omnivores and predators,
therefore their mouths and claws are exposed to microorganisms foun9 in the
prey they eat and the dirt they forage:
The patient was kept on bed rest the first few days in the hospital in the
Trendelenburg position, where the head is slightly lower than the lower
extremities. The wound was left open and the circumference of the wound was
measured on a daily basis. The sutures applied at the first facility were removed
at this time and some initial improvement in the color of the flap was noted.
Evaluation/Examination
Five days after the accident, on September 3, 1998, an evaluation for
hydrotherapy' was completed and the patient was ordered to receive
hydrotherapy on a daily basis. Upon initial evaluation, no odor was present, and
drainage was minimal and sanguineous. The color showed black and white
slough throughout the wound bed with areas of blue between the three open
lacerations. Therapists were unable to accurately assess the amount of necrotic
and granulated tissue at this time. There were three different open lacerations
and their measurements were taken. The medial proximal open laceration
measured a length of 2 cm (centimeters) and a width of 4.2 cm. The medial
distal open laceration measured a length of 11 cm and a width of 1.8 cm. The
most lateral open laceration measured a length of 27 cm and a width of 4 cm.
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Range of motion (ROM) in the right ankle anp knee were limited and the ankle
was held in plantar flexion when the patient was resting. There was no sensation
present in any of the open laceration areas. The patient's mobility was
decreased and the patient did not bear weight on the right lower extremity. A
front-wheeled walker was used as an assistive device. A problem list was made
and included: 1) Lacerations to right lower extremity, 2) Necrotic tissue present,
3) Edema, 4) Decreased ROM in the right lower extremity. Goals were set and
included: 1) Decrease edema with elevation, increased weight bearing, and
increased ROM, 2) Debride sloughing tissue as needed, 3) Increase ROM with
weight bearing and therapeutic exercise, 4) Patient to be independent with
therapeutic exercise, weight bearing, and gait. The treatment plan was to see
the patient on a daily basis for whirlpool, therapeutic exercise, ROM, patient
education, debridement, and dressing changes. On the day the evaluation was
performed, the patient was treated in the Hubbard tank for twenty minutes and
the wound bed was lightly cleaned with a 4x4 while the leg was immersed in the
water.
Treatmentll ntervention
The patient arrived the day after the initial hydrotherapy evaluation was
performed ambulating with a cane. At this time, the patient had been discharged
from the hospital and was being seen as an outpatient by hydrotherapy. For the
first five treatment sessions, the patient was treated for twenty minutes in the
Hubbard tank and the wound was dressed with SoftSorb pads or Xeroform, an
ABO pad and burn net. Range of motion exercises and heel cord stretches were
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also initiated at this time. It was noted that the entire flap of skin, which had been
surgically reattached after the accident, was becoming necrotic. It was decided
by the plastic surgeon after the first five treatments that maggot therapy would be
initiated to prepare the wound bed for the STSG to be performed at a later date.
Prior to applying the maggots, the plastic surgeon debrided the middle portion of
the black, necrotic flap of skin to allow room for the placement of the maggots.
The necrotic borders of the wound were left alone so that the healthy surrounding
tissue would not be damaged. The maggots were used for a total of four
treatment sessions and were replaced every third day or every 48 hours. The
maggots were inserted into the wound bed via saline soaked 4x4s. The netting
was secured with hypa-fix tape, and then an ABO pad for collecting drainage,
and burn net were put into place. The patient and his spouse were instructed on
the proper care of the maggots, how to change the top dressing (ABO and burn
net), and on the signs and symptoms of infection. During the treatments with
maggots, there were some complaints by the patient that the dressing design
was not containing the maggots and that there was an increase in odor. He also
noted that he could feel the maggots crawling around on his healthy tissue.
After the fourth treatment with maggots, hydrotherapy was discharged
secondary to the patient checking into the hospital for a second time. At this time
the patient complained of a fever (102 OF), fatigue, chills, and shivers. His
platelets were elevated secondary to the inflammatorylinfection phase reaction
and blood cultures were positive for Staphylococcus aureus, Pseudomonas
aeruginosa (multi-drug resistant), and Serratia. It was necessary to change the
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type of antibiotics at this time from Piperacillin to Ampicillin Sulbactam and then
finally to Meropenem to kill the infection. The day the patient checked into the
hospital, he was kept on bed rest with the lower extremity elevated and was only
allowed bathroom privileges. A hydrotherapy re-evaluation was performed on
September 18, 1998, the day the patient was re-admitted to the hospital.
The re-evaluation noted the size of the entire wound bed was 27 x 14 cm.
The odor was fowl and there was 20% necrotic tissue and 80% granulation,
although the granulated tissue was not a good color. The color of the wound was
deep red/purple granulation with yellow/gray slough. Brownish purulent drainage
was present. Edema was noted on the right medial and distal lower leg. ROM
and se!lsation were not tested however the patient was assessed for crutches.
Two new goals were set, 1) Accelerate healing process, 2) Monitor for infection.
All of the maggots were removed and the wound was dressed with a wet to dry
gauze dressing, Kerlix roll, and burn net.
The day after the patient was admitted to the hospital with the infection
and the re-evaluation was completed, hydrotherapy was continued. The patient
was put in the Hubbard tank for twenty minutes and the wound was dressed with
a wet-to-dry dressing, Kerlix, and burn net. Three days after the infection, a
STSG was performed. There was 90% granulation in the wound bed prior to the
graft being performed because it is important to have a clean, red wound with
good circulation in .order for the graft to take. The skin graft was taken from the
anterior and lateral surface of the patient's right thigh and was then placed on the
open wound of the calf. A porcine xenograft (pig skin) was then placed on the
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donor site of the thigh. Extra pieces of the graft taken from the thigh that were ·
not used were stored in a refrigerator in case portions of the graft did not take.
The graft and donor site were left open to the air after the surgery and a mixture
of rosewater and glycerin were sprayed onto the sites to keep them moist. The
patient was instructed on "rolling" the sites with Q-tips to rid it of pus and to keep
the graft level. The patient was on bed rest post-operatively.
Two days after the STSG, the patient was seen by physical therapy for
heel cord stretches, upper extremity blue thera-band exercises, and a footboard
was put into place at the end of his bed to maintain the right foot in neutral.
Three days after the STSG was performed, the patient was placed in the
Hubbard tank again with no agitation for twenty minutes and then blotting was
performed with a 4x4. The patient also began ambulation in hydrotherapy at this
time. Six days after the graft was performed, it was necessary for the plastic
surgeon to debride some areas of the wound where the graft did not take. The
.remaining tissue graft that was stored in the refrigerator was re-applied to the
debrided areas. The newly re-applied grafts did not take because it was felt that
they were left in the refrigerator for too long. Although the graft did not take in
certain areas of the wound, the wound managed to heal on its own.
The remaining treatments in hydrotherapy included the Hubbard tank for
twenty minutes, debridement with either a 4x4 or scissors and forceps, and
dressing of an ABD pad and burn net. Eventually tubi-grip was used to help
control any edema that was present. Prior to discharge from hydrotherapy, the
wound measured 19.6 cm x 13 cm with good granulation present and migration
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from the edges of the wound bed. The patient was discharged from physical
therapy services at this time and was to continue with his plastic surgeon.
Table 2 includes a summary of the subject's treatments and events from
the time of the accident through to the time of discharge from physical
therapy/hyd rotherapy.

Table 2. Summary of the client's medical treatments and events

8/30/98
9/3/98
9/3/98 to 9/9/98

Accident occurred
Initial
roth
evaluation
Hubbard tank x 20', SoftSorb dressing or Xeroform
with ABO, burn net, ROM exercises, heel cord
stretches

9/23/98

Heel cord stretches, UIE exercises with blue theraband footboard on bed ut in ace
Hubbard tank x 20' or whirlpool x 20', debridement
with 4x4 (blotting) or scissors and forceps, Kerlix,
liquid Elase, ABO, net, Santyl, Tubi-grip, "over the
counter" Jobst (knee-high), ambulation, heel cord and
hamstri
stretches
Discharge from hospital, outpatient status

9/24/98 to 10/19/98

9/26/98
9/27/98
10/19/98

Areas of graft debrided and additional skin graft
ed
Discharged from PT
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CHAPTER IV
RESULTS
The history of maggot debridement therapy, biology, mechanisms of
wound debridement, indications and contraindications of use, clinical application,
dressing design, and the advantages and disadvantages were determined
through the review of several journal articles and personal interviews.
The patient included within the case study responded well to different
treatment techniques implemented and was seen approximately one and a half
months by hydrotherapy for a total of thirty-four treatment sessions. The total
cost of treatment in hydrotherapy was approximately $6,005.00 and costs
included one evaluation, one re-evaluation, Hubbard tank, whirlpool, semiselective debridement, and selective maggot debridement therapy.
To record this patient's progress in hydrotherapy, measurements of the
wound bed were, recorded. The amount of tissue granulation and necrosis were
recorded before the split-thickness skin graft (STSG) was performed. Table 3
shows how the four sessions of maggot therapy helped increase the amount of
granulated tissue and decrease the amount of necrotic tissue and slough to help
prepare the wound for the STSG . Table 4 shows the wound measurements
taken during the initial evaluation, the re-evaluation, and at the time of the
patient's discharge.
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Table 3. Percentages of necrotic and granulated tissue throughout
hydrotherapy

9/3/98 (Initial Evaluation)

Unable to assess

PTs unable to
accurately assess at
this time

9/6/98

9/14/98***
9/15/98***

50% Necrotic
50% Yellow/gray slough

9/17/98***

30-40% Yellow adherent
>40% Granulation
slou h, remaini
is necrotic
9/18/98 (Re-evaluation)
20% Necrotic with
80% Granulation
slou
80% Granulation
90% Granulation
***Patient received Maggot Therapy from 9/9/98 to 9/18/98

Table 4. Wound measurements throughout hydrotherapy treatment

9/3/98
Initial PT evaluation

9/18/98
PT re-evaluation
10/16/98
Discha
from PT

3 separate lacerations
• medial proximal = 2 x 4.2 cm
• medial distal = 11 x 1.8 cm
• most lateral = 27 x 4 cm
27 x 14 cm
19.6 x 13 cm
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· A total of four sessions of maggot therapy were applied over a span of
eleven days. An increase in the amount of tissue granulation was increased from
50% to 90% in approximately eight days. Four days after maggot debridement
therapy was complete, the wound bed was at 90% granulation and the wound
bed was ready for the skin graft surgery.
Figures 5 through 11 illustrate the wound's progression from September 4,
1998 to October 16, 1998, the time of discharge from hydrotherapy.

Figure 4. September 4, 1998 (five days after the bear attack).
[The flap is sutured and three separate lacerations are present.
The medial proximal laceration measures 2x4.2 cm, the medial
distal laceration measures 11 x1.8 cm, and the lateral laceration
measures 27x4 cm].
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Figure 5. September 8, 1998 (nine days after the attack). [One day
before wound debrided in preparation for maggot debridement
therapy. Maggot therapy initiated on September 9, 1998].

Figure 6. September 12, 1998 (thirteen days after the attack).
[After one session of maggot therapy].
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Figure 7. September 14, 1998 (fifteen days after the attack).
[After two sessions of maggot therapy, there is 50% granulation
and 50% necrotic tissue present. The silvery-slimy tissue left
behind by the maggots is visible].

Figure 8. September 17, 1998 (eighteen days after the attack) .
[After three sessions of maggot therapy, there is greater than 40%
granulation and 30 to 40% slough (the remaining is necrotic). The
wound bed has good blood supply. Wound measures 27 x 14 cm].
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Figure 9. September 29, 1998 (thirty days after the attack). [The STSG
was completed on September 21, 1998. Additional graft was placed over
areas of the leg that did not take on September 27, 1998].

Figure 10. October 16, 1998 (forty-seven days after the attack). [Wound
bed measures 19.6 x 13 cm and graft is healing nicely. Patient discharged
from hydrotherapy services on October 19, 1998].
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CHAPTER V
DISCUSSION
To better understand the concept of maggot debridement therapy (MDT),
it was first necessary to learn about the history of use, certain biological
processes, and clinical applications. This background information aided in the
process of reviewing the client's chart for the case study. By having a better
understanding of the history, biology, mechanisms of wound healing,
indications/contraindications, dressing design, advantages/disadvantages,
clinicians can better explain it to their patients and appear, as well as feel, more
confident with treatment sessions.
The subject responded well to MDT two years ago in preparation for the
soft tissue skin graft to his right lower leg. The amount of time in therapy was
minimal when compared to several studies involving stubborn non-healing ulcers.
The client was compliant with his treatment sessions, exercises, and stretches
and he consented to MDT. The problem of infection did arise and delayed the
healing process, as was expected by the physician. The wound's progression
was monitored through measurements (length x width), percent granulation and
necrosis, tracing onto a plastic grid, and with photographs. Photographs are an
excellent way to monitor changes and they not only show changes in size, but in
color toO.48 When using photographs, it is important to include an identification
marker located next to the wound. The marker is made by taping a plastic
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measuring sheet to a 3x5 card and then placing the card inside of a plastic
sandwich bag. On the outside of the bag, the patient's identification, date, and
location of wound can be written on a white tape to stick on the outside of the
bag. Once the photograph is taken, the bag can be thrown away but the 3x5
card is used again. Today, digital cameras exist that have computer software
that performs the wound measurements as well as color monitoring. For uniform
recording, it is important to keep the same distance from the camera to the
wound. In this case study, the photographs do not have a measuring sheet
located next to the wound in the photograph. This particular facility takes their
pictures with a digital camera and then the images are saved on a computer.
The measurements are taken with a disposable ruler and the measurements are
recorded. I think that it is a good idea to have a measuring sheet in every picture
because it is easier to compare photographs at a glance rather than having to
look at measurements on another sheet.
Certain assessment tools are available to monitor wound healing such as
the 'Sussman Wound Healing Tool (SWHT) and the Pressure Sore Status Tool
(PSST). The SWHT49 was developed to track the effectiveness of physical
therapy technologies used for pressure sore ulcers. This tool is composed of two
parts including ten tissue attributes and nine descriptive attributes of size. This
tool was found to be reliable and clearly shows wound progression or risk. The
documentation is simple and it is easy to use, taking approximately five minutes.
This tool could be modified to include the type and amount of granulated or
necrotic tissue, amount of slough, presence of odor, and if edema is present.
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The Pressure Sore Status Tool (PSST) is another tool that should be considered
as an assessment tool and it was found to be valid. 50 It is composed of 15 items
that are scored from 1 to 5, except for size and location. The PSST appears to
cover almost all areas of wound care and therefore would be helpful in the clinic,
however both the SWHT and the PSST could be combined into one unique form.
When using an assessment tool or if composing your own, important
components should include: name, medical records number, examiner's name,
dates, size (area), shape, depth/stage/edges, necrotic tissue (type, amount,
slough), exudate (type, amount, odor, infection), granulation, contraction,
undermining, epithelialization, color, edema, induration, maceration, hemorrhage,
location (human body diagram to draw on), risk of skin breakdown , and the
wound healing phase. 48-5o
An assessment tool, such as the SWHT and the PSST, were not used for
the patient included within the case study. Although both of these tools are
designated for pressure sores, it is felt that either, or a combination of both, could
be used in a facility for any type of wound, even those including traumatic
injuries.
No studies with the use of MDT for a wound secondary to a bear attack
could be located and most of the other studies reviewed involved patients with
pressure sores, diabetes, or other debilitating conditions. One study of a 75year-old man suffering from Iymphostasis was located. 2 Gangrene developed on
his left leg below the knee and the wound was infected with Streptococcus
aureus. The infection remained even after surgical debridement and disinfection
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were performed. A skin graft could not be performed with the infection so MDT
was initiated five days a week with the maggots left in place for 24 hours. Within
two weeks, the entire infected area was clean and granulated tissue was present.
After MDT was complete, the patient was referred for his autologous skin graft.
Although this patient was older and more debilitated than the patient in this case
study, the maggots cleansed the wound in two weeks and prepared the leg for a
skin graft. The maggots in both cases were successful in preparing an infected
lower leg wound for a skin graft in approximately the same amount of time.
Limitations to this study are that the problem of infection, as anticipated by
the patient's doctor, did arise and may have delayed the patient's healing time.
The plastic surgeon who treated this patient retired recently and was not able to
be contacted for questions. Another limitation was that the initial evaluation
measured three different lacerations, whereas the final discharge note measured
the entire open wound remaining after the STSG. This made it hard to compare
. the initial evaluation to the patient's final discharge note from hydrotherapy,
therefore progression was more easily noted by comparing the percent of tissue
necrosis and granulation. The percent of tissue granulation and necrosis were
not recorded on the first day of maggot debridement therapy (9/9/98) or on the
second session of maggot therapy (9/12/98), making it hard to analyze the gains
made with the maggots. No specific studies on a patient with a bear attack who
received MDT was located and therefore it was difficult to compare this study's
results to another resource. One final limitation to the study is that the wound
bed was debrided by the plastic surgeon before the application of the maggots
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and therefore the photographs make it look like the maggots debrided an
exceedingly large amount of necrotic tissue.
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CHAPTER VI
CONCLUSION
Maggot debridement therapy (MDT) has been used as a form of wound
treatment since the Civil War. The species of fly used today is Lucilia sericata or
Phaenicia sericata, and a majority of wound types treated includes ulcers,
pressure sores, and traumatic injuries. The history, biological processes, and
clinical use rese'arched in this study are important for clinicians to understand
when using MDT. This background information, in the form of a literature review,
is presented in one concise resource and will be useful for those clinicians
already using MDT in the clinic or for those clinicians or students who are
interested in considering their use. The case study included presents how MDT
was used after a traumatic accident to prepare an infected wound for a splitthickness skin graft. Good results were achieved in what is felt was a minimal
amount of time. The Wyoming facility protocol presented will allow other
departments using MDT to compare their own protocol with the one presented
here and to evaluate its effectiveness.
The method of clinical application is one of trial and error and can depend
on the supplies available in the clinic. The dressing design should be "cage-like"
in order to contain the larvae. Patients need to be prepared for this type of
therapy and therefore should have a thorough explanation before their treatment
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begins. It is felt that the advantages outweigh the disadvantages and that this
form of treatment can be used for many different cases. It has been felt that if
MDT were used earlier in treatment, rather than as a last resort treatment, that
even greater gains could be made in healing. 46 This earlier application of
maggots would prevent the need for topical or systemic antimicrobial treatment.
If maggots have been effective enough to treat patients who otherwise may have
lost limbs despite antibiotics and surgery, than we should use maggots before
wounds progress that far. Clinical studies at the Veteran Affairs Medical Center
and at the University of California 22 are still underway, however they have
already shown that MDT is more effective at cleaning infected and gangrenous
wounds than any other non-surgical treatment anod that they clean wounds in ao
shorter amount of time. With shorter treatment times, maggot debridement
therapy can be considered cost-effective. Through the years the amount of
coverage for patient treatments has decreased therefore presenting a challenge
for physical therapists as well as other healthcare workers in providing
treatments that are more effective. With shorter healing rates, the treatment
costs for patients, as well as insurance agencies, will be less. If maggots are
unable to initially be used as a treatment, than they should at least be considered
for use in conjunction with other wound care methods.
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